Research GradeSpecialtyBremelanotide
or 3 × R$ 21,67 interest-free
CONFIANÇA DOS PESQUISADORES
Central Mechanism of Action
Acts through MC4R in the CNS — a novel pathway distinct from peripheral vasodilators
>99% HPLC Purity
Every batch independently tested with full Certificate of Analysis included
FDA-Approved Derivative
Approved as Vyleesi — one of few peptides with full regulatory approval pathway
10mg Research Vial
Generous content for melanocortin receptor pharmacology research
A synthetic melanocortin receptor agonist studied for its effects on sexual function through central nervous system pathways. PT-141 is the only melanocortin-based compound FDA-approved (as Vyleesi) for hypoactive sexual desire disorder.
Acts through MC4R in the CNS — a novel pathway distinct from peripheral vasodilators
Every batch independently tested with full Certificate of Analysis included
Approved as Vyleesi — one of few peptides with full regulatory approval pathway
Generous content for melanocortin receptor pharmacology research
Choose your preferred bacteriostatic water volume for melanocortin receptor research requiring precise concentration control.
Calculate exact doses for your MC4R research protocol. Clinical studies used 1.75mg subcutaneous — reconstitute to your needs.
Lyophilized form stable for 24+ months when stored properly at 2-8°C. The cyclic structure provides inherent molecular stability.
10mg vials provide substantial research material — approximately 5-6 administrations at clinical-equivalent doses.
Allow vial to reach room temperature before reconstitution
Add 2 mL bacteriostatic water slowly along the vial wall
Gently swirl until fully dissolved — do not shake
Draw desired dose using an insulin syringe
Inject subcutaneously in the abdomen
Store reconstituted vial refrigerated at 2-8°C
Utilize sempre uma agulha estéril nova para cada administração. Descarte as agulhas usadas em um recipiente apropriado para objetos cortantes. Armazene a caneta refrigerada a 2-8°C.
Stack discount applied
PT-141
R$ 65,00
This product
Melanotan II
R$ 55,00
GHK-Cu
R$ 69,00
Preço do pack — economize R$ 18,90 com esta combinação
Cyclic melanocortin receptor agonist (MC4R-selective)
C50H68N14O10
1,025.18 g/mol
Approximately 2.7 hours
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
PT-141 (Bremelanotide) activates the melanocortin-4 receptor (MC4R) in the central nervous system, modulating sexual desire and arousal pathways. Unlike PDE5 inhibitors that act peripherally, PT-141 works through central nervous system mechanisms, representing a novel approach to sexual dysfunction research.
RECONNECT Phase 3 trials demonstrated statistically significant improvement in sexual desire and distress scores in premenopausal women with HSDD.
Approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women — the first melanocortin-based therapeutic approved.
Confirmed central mechanism of action through MC4R in the hypothalamus, distinct from peripheral vasodilator mechanisms.
“Having access to research-grade PT-141 at this purity level is valuable for our melanocortin pharmacology studies. Excellent supplier.”
Dr. R. Thompson
Neuropharmacology Research, London
“We use PT-141 in our MC4R receptor binding assays. Peptides Pharma's purity is consistently excellent across batches.”
Dr. M. Antonova
Receptor Pharmacology, Prague
“The 10mg vial provides good value for our research needs. Quality is reliable and shipping to our lab was prompt.”
Dr. J. Park
CNS Research, Seoul
“PT-141 (bremelanotide) is essential for our melanocortin pathway research. The Peptides Pharma vial quality is outstanding — proper lyophilization, verified purity, and detailed COA. Highly professional supplier.”
Dr. S. Nielsen
Oslo, Norway
PDE5 inhibitors (sildenafil, tadalafil) work peripherally on blood vessels. PT-141 works centrally through MC4R in the brain, modulating desire and arousal pathways. It is the first centrally-acting compound approved for sexual dysfunction.
COA incluído em cada pedido. Relatórios específicos por lote disponíveis sob solicitação.
See how Peptides Pharma pre-mixed research vials compare to traditional vials and other suppliers.
| Feature | Peptides Pharma Pens | Traditional Vials | Other Suppliers |
|---|---|---|---|
| Format | Lyophilized vial | Lyophilised powder | Mixed |
| Purity | >99% verified | Variable (70-95%) | Claims vary |
| Dosing accuracy | <2% error | ~15% error | N/A |
| Reconstitution needed | No | Yes | Sometimes |
| Contamination risk | Sealed system | Multi-use vial | Varies |
| COA included | Every order | Rarely | Sometimes |
| GMP certified | Yes | Rarely | Some |
| EU customs-free | Yes | Often no | Varies |
Este produto destina-se exclusivamente a uso laboratorial e de pesquisa. Não se destina ao consumo humano.
Sistema de caneta premium com dosagem totalmente ajustável. Fabricação GMP, pureza >99% garantida.
Buy Melanotan II >99% purity, GMP certified. Non-selective melanocortin agonist for melanogenesis research. Vials from €69 with worldwide delivery.
ARTICLEBuy PT-141 (Bremelanotide) >99% purity, GMP certified. MC4R agonist for CNS and sexual function research. Vials from €79 with worldwide delivery.
COMPARISONCompare PT-141 and Melanotan II for melanocortin research. Selective MC receptor targeting vs broad melanocortin activity. Buy >99% purity research peptides.
ENCYCLOPEDIAMelanocortin Receptor Agonist (MC3R/MC4R). Molecular weight: 1025.18 Da. Explore mechanism of action, key studies, and research applications.
BUNDLEThe most studied peptide duo in tissue regeneration research
PROTOCOLResearch protocol combining BPC-157 and TB-500 lyophilized vials for accelerated tissue recovery. Explore synergistic healing mechanisms, dosing schedules, and published study findings.
FAQPT-141 (Bremelanotide) research FAQ. Learn about melanocortin receptor mechanisms, sexual function research, purity, storage, and research applications.
CATEGORYResearch-grade sexual health peptides. PT-141 (Bremelanotide) melanocortin receptor research, Melanotan II, CJC-1295, Ipamorelin for CNS pathways & GH optimisation. >99% purity, worldwide delivery.
